[1] He coined the term "white-coat hypertension" to describe those whose blood pressure was elevated in the doctor's office, but normal in everyday life.
He moved to the Radcliffe Infirmary, Oxford in 1968 to undertake a Medical Research Council Fellowship and then became a registrar within the Nuffield Department of Clinical Medicine.
Pickering continued his work as Director of the Integrative and Behavioral Cardiology Program at Mount Sinai Hospital in New York City in 2000, finally relocating to Columbia University Medical Center in New York City in 2003 to form the Center for Behavioral Cardiovascular Health where he worked until his death in 2009.
He served as Secretary and Program Chair of the American Society of Hypertension, and was on the Food and Drug Administration's Cardio Renal Advisory Board.
His research focused on his core belief that much of cardiovascular disease arises from psychosocial factors, and is hence potentially preventable or treatable by modifying these.
Selected publications; see list of available records in PubMed: A three-page biography: Thomas G. Pickering: friend, colleague and scientist by Eoin O’Brien and William B.